PARP1 and ovarian cancer: In PARPi‐resistant ovarian cancer cells, the liquid–liquid phase separation (LLPS) of KAT6A reduced the cytotoxic effects of PARPi treatment by releasing PARP1 trapped at the DNA break sites.